Long Path Partners, the investment entity pursuing the acquisition of Idox PLC, has disclosed that it has secured aggregate support for approximately 49.26% of the software company's shares in relation to its cash offer of 71.5 pence per share. This figure, revealed through regulatory filings, incorporates the bidder's own holdings alongside both binding undertakings and non-binding letters of intent from other shareholders. The development places the suitor tantalizingly close to the crucial majority threshold required to declare the offer unconditional.
The Threshold for Success
For the takeover to proceed, Long Path must secure acceptances representing more than 50% of Idox's voting rights. The current support level of 49.26% leaves a narrow gap to bridge. The offer is scheduled to remain open until 1:00 PM London time on March 16, 2026, setting a clear deadline for the bidder to garner the necessary additional backing. Market participants are closely monitoring the pace of formal acceptances as this date approaches.
As of the most recent update, valid acceptances received by Frankel UK Bidco, the vehicle for the offer, stood at approximately 19.12% as of 4:30 PM on February 5. When accounting for additional shares deemed supportive under the acceptance condition, this proportion rises to around 25.34%. This distinction between non-binding support and formal, valid acceptances is a critical point of analysis for arbitrage investors, as letters of intent do not legally obligate shareholders to tender their stock and they remain free to trade their holdings or change their stance.
Market Price Action and Investor Sentiment
Idox shares concluded trading on Friday, February 7, at a price of 71.0 pence, representing a marginal gain of 0.20 pence on the session. This closing price sits roughly 0.7% below the 71.5 pence offer price. The stock's persistent trading at a slight discount to the bid reflects the market's assessment of execution risk and the remaining time until the offer deadline. Concurrently, the FTSE AIM 100 index, on which Idox is listed, advanced by 0.56% according to data from Hargreaves Lansdown.
Recent trading activity, as indicated by a Form 8.5 disclosure from broker Peel Hunt, showed client transactions in Idox shares on February 5 at prices predominantly between 70.8 and 71.0 pence, illustrating active two-way flow as investors position themselves ahead of the mid-March cutoff. The market's focus is now squarely on whether the share price will converge with the offer price as the deadline nears and perceived risk diminishes, or if the discount will persist or even widen should doubts emerge about reaching the 50% threshold.
Background and Strategic Rationale
The proposed acquisition was initially announced in October 2025, with Long Path Partners agreeing to acquire Idox for an enterprise value of approximately £339.5 million. Idox is a specialist provider of software solutions for public sector applications, including government planning, regulatory compliance, and electoral management technology. The bid at 71.5 pence per share represented a significant premium to the company's undisturbed trading price, aiming to provide shareholders with an attractive cash exit.
The primary risk for arbitrageurs and shareholders considering the offer is the potential for the deal to lapse if the 50% acceptance condition is not satisfied by the deadline. In such a scenario, the offer could be withdrawn, renegotiated, or extended. Historically, the share price of a target company often retreats toward its pre-bid trading range if a proposed acquisition collapses, posing a downside risk for those who bought shares in anticipation of the deal completing at the offer price.
Looking ahead, the key milestones for the market to watch will be any new regulatory filings that show an acceleration in formal acceptances. The decisive moment will come if and when Long Path Partners announces it has crossed the 50% voting rights threshold, at which point it is expected to declare the offer unconditional. Until that announcement, the slim differential between the market price and the offer price will continue to reflect the remaining uncertainty surrounding this strategic transaction.
